SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (14770)9/20/2000 12:13:27 AM
From: Robert K.  Read Replies (1) | Respond to of 17367
 
You have NOT answered my question BLUE. ONCE again, how would you have designed the meningo trial within the framework of th FDA?



To: Bluegreen who wrote (14770)9/20/2000 12:27:53 AM
From: Robert K.  Read Replies (1) | Respond to of 17367
 
OT BLUE. you scared of the buggie man or what? I go nite nite shortly.



To: Bluegreen who wrote (14770)9/20/2000 2:13:42 PM
From: Cacaito  Read Replies (1) | Respond to of 17367
 
Blue, your theory is more acceptable now, still needs to be prove. Bpi could end up as a preventive tool ( 2ry prevention, once the patient is infected) and to avoid full shock, maybe the zovant/pafase/antiC14 will do the work at a later stage.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News